Clinical Trial Update: Study on c-Met Targeted PET/CT Imaging in NSCLC [NA]

View source ↗

Summary

A clinical trial is evaluating a c-Met targeted PET/CT imaging tracer in non-small cell lung cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• c-Met targeted PET tracer

Snippet

Sponsor: Xilin Sun | Conditions: PET/CT Imaging, NSCLC | NA | Status: RECRUITING